Title:
CD3-TARGETING MULTISPECIFIC ANTIBODY AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/141856
Kind Code:
A1
Abstract:
Provided in the present application are a CD3-targeting multispecific antibody and the use thereof.
Inventors:
YANG YI (CN)
LI JIE (CN)
CHEN JI (CN)
YANG YANG (CN)
LI JIE (CN)
CHEN JI (CN)
YANG YANG (CN)
Application Number:
PCT/CN2022/074201
Publication Date:
August 03, 2023
Filing Date:
January 27, 2022
Export Citation:
Assignee:
GLYCO THERAPY BIOTECHNOLOGY CO LTD (CN)
UNIV NANJING (CN)
UNIV NANJING (CN)
International Classes:
C07K19/00; A61K39/395; A61P35/00; C12P19/28
Domestic Patent References:
| WO2021089609A1 | 2021-05-14 |
Foreign References:
| TW202140075A | 2021-11-01 | |||
| JP2017200902A | 2017-11-09 | |||
| JP2017197512A | 2017-11-02 | |||
| CN112760292A | 2021-05-07 | |||
| CN107847559A | 2018-03-27 | |||
| CN112638403A | 2021-04-09 | |||
| CN113248605A | 2021-08-13 |
Other References:
WANG, WEI ET AL.: "Chemoenzymatic Synthesis of GDP-L-Fucose and the Lewis X Glycan Derivatives", PNAS, vol. 106, no. 38, 22 September 2009 (2009-09-22), XP055093077, DOI: 10.1073/pnas.0908248106
EIGENBROT, C. ET AL.: "Structural Basis for High-Affinity HER2 Receptor Binding by an Engineered Protein", PNAS, vol. 107, no. 34, 24 August 2010 (2010-08-24), XP009148172, DOI: 10.1073/pnas.1005025107
EIGENBROT, C. ET AL.: "Structural Basis for High-Affinity HER2 Receptor Binding by an Engineered Protein", PNAS, vol. 107, no. 34, 24 August 2010 (2010-08-24), XP009148172, DOI: 10.1073/pnas.1005025107
Attorney, Agent or Firm:
SHANGHAI DIANSHI PARTNERS, P.C. (CN)
Download PDF: